B.E. de Pauw

5.9k total citations
119 papers, 3.4k citations indexed

About

B.E. de Pauw is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, B.E. de Pauw has authored 119 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 52 papers in Infectious Diseases and 45 papers in Oncology. Recurrent topics in B.E. de Pauw's work include Antifungal resistance and susceptibility (44 papers), Neutropenia and Cancer Infections (37 papers) and Fungal Infections and Studies (37 papers). B.E. de Pauw is often cited by papers focused on Antifungal resistance and susceptibility (44 papers), Neutropenia and Cancer Infections (37 papers) and Fungal Infections and Studies (37 papers). B.E. de Pauw collaborates with scholars based in Netherlands, Belgium and United States. B.E. de Pauw's co-authors include J. Peter Donnelly, Jacques F. Meis, Paul E. Verweij, J. A. A. Hoogkamp‐Korstanje, Willem J. G. Melchers, Antonius J. M. M. Rijs, Alex van Belkum, Nicole M. A. Blijlevens, John Raemaekers and I.R.O. Nováková and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

B.E. de Pauw

117 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.E. de Pauw Netherlands 32 1.8k 1.7k 988 503 370 119 3.4k
Ben de Pauw Netherlands 21 2.6k 1.4× 2.5k 1.5× 1.1k 1.1× 479 1.0× 356 1.0× 41 4.0k
Corrado Girmenia Italy 36 3.2k 1.8× 3.0k 1.8× 1.2k 1.2× 361 0.7× 417 1.1× 138 4.8k
James I. Ito United States 28 2.0k 1.1× 2.4k 1.5× 2.7k 2.7× 382 0.8× 1.1k 3.1× 57 5.4k
Ali J. Olyaei United States 27 1.7k 0.9× 1.8k 1.1× 326 0.3× 372 0.7× 128 0.3× 70 3.9k
P. M. Shah Germany 22 2.0k 1.1× 2.2k 1.3× 565 0.6× 289 0.6× 285 0.8× 103 3.7k
Harrys A. Torres United States 35 1.7k 0.9× 2.4k 1.4× 586 0.6× 199 0.4× 86 0.2× 114 3.6k
K. V. I. Rolston United States 34 1.0k 0.5× 1.5k 0.9× 1.3k 1.3× 335 0.7× 631 1.7× 86 3.5k
Werner Heinz Germany 34 2.7k 1.5× 2.6k 1.5× 783 0.8× 294 0.6× 126 0.3× 91 3.5k
David Helfgott United States 15 1.4k 0.8× 1.5k 0.9× 757 0.8× 203 0.4× 99 0.3× 23 3.0k
Maha Boktour United States 24 942 0.5× 1.1k 0.7× 417 0.4× 240 0.5× 180 0.5× 31 2.6k

Countries citing papers authored by B.E. de Pauw

Since Specialization
Citations

This map shows the geographic impact of B.E. de Pauw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.E. de Pauw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.E. de Pauw more than expected).

Fields of papers citing papers by B.E. de Pauw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.E. de Pauw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.E. de Pauw. The network helps show where B.E. de Pauw may publish in the future.

Co-authorship network of co-authors of B.E. de Pauw

This figure shows the co-authorship network connecting the top 25 collaborators of B.E. de Pauw. A scholar is included among the top collaborators of B.E. de Pauw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.E. de Pauw. B.E. de Pauw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pauw, B.E. de. (2011). WHAT ARE FUNGAL INFECTIONS?. SHILAP Revista de lepidopterología. 3(1). e2011001–e2011001. 40 indexed citations
2.
Greene, Reginald E., J W Oestmann, Paul Stark, et al.. (2007). Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign. Clinical Infectious Diseases. 44(3). 373–379. 394 indexed citations
3.
Pauw, B.E. de. (2006). Increasing Fungal Infections in the Intensive Care Unit. Surgical Infections. 7(supplement 2). s–93. 18 indexed citations
4.
5.
Walsh, Thomas J., Gerald R. Donowitz, & B.E. de Pauw. (2005). Caspofungin versus liposomal amphotericin B for empirical therapy.. New England Journal of Medicine. 352. 410–414. 1 indexed citations
6.
Blijlevens, Nicole M. A., J. Peter Donnelly, & B.E. de Pauw. (2005). Microbiologic consequences of new approaches to managing hematologic malignancies.. PubMed. 9(2). E2–E2. 6 indexed citations
7.
Lashof, Astrid M. L. Oude, R. De Bock, Raoul Herbrecht, et al.. (2004). An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. European Journal of Cancer. 40(9). 1314–1319. 28 indexed citations
8.
Blijlevens, Nicole, Belinda van’t Land, J. Peter Donnelly, Laura M’Rabet, & B.E. de Pauw. (2004). Measuring mucosal damage induced by cytotoxic therapy. Supportive Care in Cancer. 12(4). 227–233. 46 indexed citations
9.
Donnelly, J. Peter, et al.. (2002). Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition. Transplant Infectious Disease. 4(2). 64–65. 13 indexed citations
10.
Pauw, B.E. de, Raoul Herbrecht, & F. Meunier. (2002). Achievements and goals of the EORTC Invasive Fungal Infections Group. European Journal of Cancer. 38. 88–93. 7 indexed citations
11.
Pauw, B.E. de, et al.. (2001). Reliability of clinical research on invasive fungal infections: a systematic review of the literature. Medical Mycology. 39(1). 35–40. 1 indexed citations
12.
Pauw, B.E. de & E. Anaissie. (1997). Controversies in management of candidiasis in neutropenic patients treated for malignant diseases: new versus old or better versus worse. International Journal of Infectious Diseases. 1. 2 indexed citations
13.
Pauw, B.E. de & J. Peter Donnelly. (1997). Infectious Complications of Cancer: Controversies in the Antibacterial Treatment of Patients with Neutropenia: A Matter of Comprehension or Apprehension?. Cancer Investigation. 15(1). 37–46. 3 indexed citations
14.
Pauw, B.E. de. (1997). Practical modalities for prevention of fungal infections in cancer patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(1). 32–41. 26 indexed citations
15.
Severens, Johan L., J. Peter Donnelly, Jacques F. Meis, et al.. (1997). Two Strategies for Managing Invasive Aspergillosis: A Decision Analysis. Clinical Infectious Diseases. 25(5). 1148–1154. 40 indexed citations
16.
Pauw, B.E. de, John Raemaekers, J. Peter Donnelly, Bart Jan Kullberg, & Jacques F. Meis. (1995). An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Annals of Hematology. 70(2). 83–87. 30 indexed citations
17.
18.
Donnelly, J. Peter, et al.. (1993). Failure of Clindamycin to Influence the Course of Severe Oromucositis Associated with Streptococcal Bacteraemia in Allogeneic Bone Marrow Transplant Recipients. Scandinavian Journal of Infectious Diseases. 25(1). 43–50. 36 indexed citations
19.
Koopmans, P.P., et al.. (1993). Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia. European Journal of Cancer. 29(4). 515–518. 7 indexed citations
20.
Janssen, J, Heinz Ludwig, Werner Scheithauer, et al.. (1985). Phase I Study of Recombinant Human Interferon Alpha-2C in Patients with Chemotherapy-Refractory Malignancies. Oncology. 42(1). 3–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben de Pauw Breakdown of academic impact, for papers by Corrado Girmenia Breakdown of academic impact, for papers by James I. Ito Breakdown of academic impact, for papers by Ali J. Olyaei Breakdown of academic impact, for papers by P. M. Shah Breakdown of academic impact, for papers by Harrys A. Torres Breakdown of academic impact, for papers by K. V. I. Rolston Breakdown of academic impact, for papers by Werner Heinz Breakdown of academic impact, for papers by David Helfgott Breakdown of academic impact, for papers by Maha Boktour
Rankless by CCL
2026